Supply Disruption Alert: Repaglinide 1mg and 2mg tablets – Updated
Update (13/05/2021): both strengths back in stock
Department of Health and Social Care (DHSC) has issued a medicine supply disruption alert for Repaglinide 1mg and 2mg tablets
Alert reference: SDA/2021/005
Viatris are currently out of stock of repaglinide 1mg and 2mg tablets until early May 2021 due to regulatory issues. Rivopharm UK Limited are out of stock due to manufacturing issues and are unable to confirm a resupply date.
- Generic repaglinide 1mg and 2mg tablets are out of stock until early May 2021
- Limited quantities of repaglinide 500 microgram tablets remain available but are unable to support any increase in demand.
- A limited quantity of Prandin (repaglinide) 500 microgram, 1mg and 2mg tablets remain available but are also unable to support any increase in demand.
- Unlicensed supplies of repaglinide 1mg and 2mg tablets have been sourced.
There is not currently a listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for Repaglinide 1mg or 2mg tablets (Imported) cannot be issued. If a prescriber is unable to issue an unlicensed EPS prescription in the correct way, then pharmacy teams should contact the prescriber for an FP10 paper prescription to be issued as ‘Repaglinide 1mg or 2mg tablets (Imported)’ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:
- Amount dispensed over pack size used;
- Invoice price per pack size from which the order was supplied less any discount or rebate;
- Manufacturers’/importers’ MHRA licence number;
- Batch number of the product supplied;
The following specialist importers have confirmed they can source unlicensed repaglinide tablets (please note, there may be other companies that can also source supplies):
For further information and for advice on the management of affected patients please view the alert here.
The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.